
Period tracking app users warned of 'frightening safety risk' amid data concerns
Period tracking apps may pose a huge privacy risk to users amid concerns about companies selling the data, according to a recent report from the University of Cambridge
Women who use period tracking apps have been warned over privacy fears that their data is being sold to third party companies. These cycle tracking apps are an increasingly popular way for women to understand their menstrual cycle and there have been over 250 million downloads of the three biggest apps - Flo, Clue and Period Tracker.
However a damning report from University of Cambridge's Minderoo Centre said the tracking apps were a "gold mine" for consumer profiling. By collecting information, it could allow companies to produce targeted advertisements linked to information users think is kept private.
The researchers also warn that if this data gets into the wrong hands, it could even affect access to abortion, health insurance discrimination and cyberstalking as well as risks to job prospects.
READ MORE: 'We're empowering women to take charge of their health - new police guidance pushes us back'
"There are real and frightening privacy and safety risks to women as a result of the commodification of the data collected by cycle tracking app companies," said Dr Stefanie Felsberger, the lead author of the report. The report calls on organisations such as the NHS and other health bodies to create a "safer" alternative that is trustworthy.
Under EU and UK law, the data from these period-tracking apps comes under a special category, which means it should have special protections from being sold on - but this report highlights that consent options are not always enforced or implemented. This then allows the data can be sold to advertisers and tech giants such as Facebook and Google.
If the data is sold on, it can be used to target women with tailored adverts for different parts of their cycle such as beauty ads popping up during ovulation, as well as ads relating to pregnancy. According to BBC, researchers said data on who is pregnant, and who wants to be, was some of the "most sought-after information in digital advertising" as it led to a shift in shopping patterns and can be up to 200 times more valuable than data on gender, age and location.
Help us improve our content by completing the survey below. We'd love to hear from you!
Dr Felsberger added: "Menstrual cycle tracking apps are presented as empowering women and addressing the gender health gap. Yet the business model behind their services rests on commercial use, selling user data and insights to third parties for profit. There are real and frightening privacy and safety risks to women as a result of the commodification of the data collected by cycle tracking app companies."
Worryingly, the data can also be used against women when it comes to having an abortion. In the UK, data from apps designed to aid women's health has been requested by police in investigations into women illegally accessing abortion services, according to a Tortoise Media investigation.
The guidance released in January 2025 by the National Police Chiefs' Council stated that women who experience a sudden unexpected pregnancy loss, and if the police suspect a miscarriage, stillbirth or early labour is the result of an illegal abortion could be investigated by the authorities.
The Mirror spoke to Rhiannon White, CEO of period tracking app Clue on the report, who said she was "disappointed" to see these headlines. "Clue was created, to give women and people with cycles the knowledge and agency around our menstrual and reproductive health that our public health systems have historically failed to.
"We firmly believe that as women and people with cycles, our health data must serve us and never be used against us or for anyone else's agenda or commercial benefit. Our app serves our user community–not the agendas of advertisers, insurance companies, data brokers, or anyone else."
The CEO continued: "We are a women-led company, CE-marked as a Class I medical device and independently governed under the strictest guidelines of the EU/UK GDPR. We always treat our member data with utmost care, taking all necessary precautions (and more) to ensure it's secure and protected.
"We are disappointed to see in these headlines how the female health experience is continually framed from a narrow fertility lens, when we know the vast majority of our members (over 97%) use the app to track a variety of menstrual and cycle related symptoms."
She added: "Our de-identified dataset powers critical research into conditions like PCOS, endometriosis, and cycle-related pain, helping to close historic gaps in women's health. The assumption that an overwhelmed public health system can exceed the quality of data protection, medical research, and user-first insight that Clue has prioritised for over a decade is something we welcome a discussion around. We see value in collaboration with any partner or public health entity who wants to join us in moving women's health forward."
Sue Khan, VP of Security and Data Protection Officer at Flo told the Mirror: "We support all efforts and research to ensure women feel as safe as possible when using their period tracking apps, and believe the highest standards of data protection must be applied by femtech services in order to protect the rights and freedoms of users.
"At Flo, implementing and advocating for best-in-class privacy practices so women's health data can be treated with the utmost respect and care is our priority, and that will never change. We have never - and will never - monetise or sell user data. We do not see personal data as a commodity, and categorically reject the notion that women's health data should be treated as a goldmine for advertising. Our business model is solely subscription-based and does not depend on the exploitation of reproductive information.
"We firmly believe it's 'your body, your data'. In 2022, Flo created Anonymous Mode, a first-of-its-kind, award-winning technology that gives users the option to access the Flo app without name, email address, or any technical identifiers being associated with their health information. This means that no one — not Flo, not authorities, no one — can identify the user upon request. We also open-sourced our Anonymous Mode, meaning that any femtech or health tech company could use this technology if they wish. Because safeguarding women's rights isn't a competitive advantage—it's a collective responsibility."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Leader Live
30 minutes ago
- Leader Live
‘Cover-ups' surrounding care of Nottingham attack killer, victim's mother claims
Valdo Calocane, who had been diagnosed with paranoid schizophrenia, killed three people – 19-year-old students Grace O'Malley-Kumar and Barnaby Webber and 65-year-old caretaker Ian Coates – and attempted to kill three more in Nottingham in June 2023. A February report into the care received by Calocane detailed how he was not forced to have long-lasting antipsychotic medication because he did not like needles, and how other patients at Nottinghamshire Healthcare NHS Foundation Trust also went on to commit 'extremely serious' acts of violence. Families of the victims met with Health Secretary Wes Streeting on Monday and said they told him they want the names of staff involved in treating Calocane to be made public. Speaking on ITV's Good Morning Britain on the second anniversary of the attack, Barnaby Webber's mother Emma Webber said of Calocane's care: 'We quite often say, imagine anything that could go wrong, did go wrong and Wes Streeting actually, to quote him, he said 'sunlight is the best disinfectant'. 'That's appropriate but, actually, I would say it's simpler than that. 'I think truth is and once you've got the truth, then you've got somewhere to begin, and we're still getting cover-ups, we're still getting mistruths and we're still getting those push-aside emails 'well, the trust will deal with that, or the inquiry will deal with that'. 'But, no, we're not going to stop. 'I don't know when they'll learn that we will not stop until we get those answers.' Ms Webber added that the families' calls for transparency were 'not a witch hunt'. She said: 'I'm sure it can come across that we as families are just so vociferous in finding answers and trying to deal with our grief and our anger and rage at what happened. 'But it's much deeper than that, and it's greater than that, because there are individuals out there that they're posing a risk themselves, but they're posing a risk to the public, and we're not on a witch hunt in what we're doing. 'We do have the statutory inquiry coming up but that shouldn't stop individuals who, just as basic as failing to do their jobs properly, from being held to account, and that's through the professional means. 'I cannot understand how the NHS have not been able to confirm that anyone has had any disciplinary action against them for what they did or didn't do during his care.' Grace O'Malley-Kumar's father, Dr Sanjoy Kumar, told the programme that the families do not have 'detailed answers' and called for 'full transparency' and 'true accountability'. He said: 'At this juncture, I think it's turned into a national representation case for us, because I think what we've realised is that every family that goes through a horrific tragedy like us, they're not given answers, and they're given a lot of kerfuffle about what happened when, that's all very interesting, the timelines are interesting, but what we want is true accountability. 'Because when we have accountability, we can then have change and positive change for the country, and we've not had that, and that's been really, really frustrating.' Calocane was sentenced to an indefinite hospital order in January 2024 after admitting manslaughter by diminished responsibility and attempted murder. He was admitted to hospital and sectioned under the Mental Health Act four times between 2020 and 2022 because of his violent behaviour and refusal to take his medication, before NHS services lost track of him and discharged him in the months before the attacks. Three reports, including one by the Care Quality Commission (CQC), described failings in his care but none included practitioners' names, Dr Kumar said after meeting Mr Streeting. On Friday, the families of the victims will hold a memorial walk through Nottingham to remember their loved ones two years after their deaths. They will meet at St Paul's Church in Lenton Road at 11.30am before walking to the two locations of the attacks. During the interview with Good Morning Britain, Ms Webber said she had a 'visceral reaction' to returning to the city, adding that 'feels almost like it was yesterday' that the attack happened. She added that the group wanted to 'walk in peace and love', and that anyone who wanted to join was 'very welcome'. In a statement, Ifti Majid, chief executive of Nottinghamshire Healthcare NHS Foundation Trust, said: 'We are committed to giving our fullest co-operation and support to the Nottingham Inquiry which has already begun to request documentary evidence from ourselves and other organisations in relation to the devastating events of June 2023. 'It would be inappropriate to comment further at this stage.' The Department of Health and Social Care has been contacted for comment.


Scottish Sun
34 minutes ago
- Scottish Sun
Ozempic-like weight loss jabs could one day be dished out like statins, says top NHS doctor
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) WEIGHT loss jabs could one day be dished out like statins, England's top doctor says. Professor Sir Stephen Powis, medical director of NHS England, said in years to come they will get cheaper and may be used to prevent a range of illnesses. 1 NHS' top doctor says weight loss jabs like Mounjaro "will become more widespread" Credit: Alamy But chief medical officer Professor Sir Chris Whitty said they are 'not a get out of jail card' and people must still try to be healthy. GPs will roll out Mounjaro across the country from this month. The injections currently cost the NHS around £100 each but prices are expected to drop over time. Research increasingly shows they have health benefits beyond diabetes and weight loss, potentially including reducing the risks of cancer, dementia and heart diseases. These are not get-out-of-jail cards Professor Sir Chris Whitty Cholesterol-lowering statins have been used for decades to reduce heart attacks and strokes and now cost next to nothing at 3p a pill. Studies suggest they also reduce the risk of dementia, though it is not what they were designed for. Prof Powis said: 'The use of statins is now very different from when they first came out and I've no doubt that will be the same for these drugs. 'I think over time it's highly likely that they will become more widespread. 'I think there will be a combination of increased evidence of positive outcomes and costs dropping, and we will learn better how to deploy them. 'It's not completely unusual for drugs over time to be found to have effects that go over and beyond what they were initially designed for. 'I am not starry-eyed about weight loss drugs but it's very exciting. 'We're in the foothills of learning how to use them.' NHS prescriptions surging NHS use of the jabs is already skyrocketing and official figures show prescriptions in England surged from 1.4million in 2023 to 2.7m in 2024. Doctors spent a total of £269million on them in the latest financial year and more than a million people are estimated to be buying them privately. Prof Whitty said it is important for people to still get help to eat healthily and exercise, as well as taking medicine. He added: 'These are not get out of jail cards. 'What we shouldn't do is use it as an excuse, as a society, not to deal with what is a rising and very serious problem.'


Metro
37 minutes ago
- Metro
I have terminal cancer and won't wait around for the painful death my wife had
It started, as these things often do, with something small – I was getting up to urinate three or four times a night. At first, I thought nothing of it. But my wife Irene insisted I get a second opinion, so I went to the GP. He suggested a PSA test and within 48 hours I got the call: 'Your results are high, Barry. You'd better come in for a chat.' After that, everything moved quickly. Scans confirmed what I feared most: Advanced prostate cancer with just five years to live. It had already spread to my ribs. I'd been feeling tired, but I was in my eighties – I thought that was just life. Suddenly it all made sense. The diagnosis hit hard, not because I feared death, but because I knew how much pain it could cause. I'd seen it before. My first wife, Sheila, died of cancer at just 52, and her death was the most traumatic thing I've ever witnessed. Sheila's symptoms started on the flight home from Florida in March 1998. She was struggling to breathe, then came the coughing and breathlessness. At first we thought it was her medication, but it continued to get worse so we consulted a doctor in August. She was diagnosed with lung cancer by September. At the time, they told us they'd caught it early. This gave us hope, but it didn't last. The cancer spread fast. She went through chemotherapy over Christmas – it made her incredibly sick and did nothing to slow the disease. She had surgery a few months later, but I knew something was wrong the next morning when she was still in intensive care. The doctors told me it had spread to her heart and that there was nothing more they could do. From there, it was straight to the hospice. The staff were brilliant – warm, skilled, tireless – but they couldn't relieve her pain. Sheila was in agony. She was screaming out that she wanted to die, injecting morphine herself and begging for the agony to end. It wasn't depression. It was desperation. She knew she wasn't going to get better and she didn't want to suffer through to the end. Sheila spent three months in that hospice. She came home briefly when they thought the cancer might be in remission, but within 10 days she was back. She died on December 28, 1999, roughly a year and a half after her diagnosis. I was there, holding her hand. My son had been keeping vigil for weeks and, that day, I finally convinced him to go home and rest. She passed within an hour of him leaving. Symptoms of prostate cancer can include: Blood in urine or blood in semen Needing to pee more frequently, often during the night Needing to rush to the toilet Difficulty in starting to pee (hesitancy) Straining or taking a long time while peeing Weak flow Feeling that your bladder has not emptied fully Source: NHS We never talked about assisted dying – back then, we didn't know it existed. But if it had been legal, I have no doubt she would have chosen it. When I was diagnosed in January 2020, I made a clear decision: No chemotherapy. Not after seeing what it did to Sheila. I started hormone treatment instead, which I still receive every 12 weeks, and it's worked really well so far. I'm proud to say that my PSA levels are low and, against the odds, I'm still here over five years later. In 2017, I started researching assisted dying and joined a Swiss organisation, lifecircle, that helps people end their lives peacefully and legally, which has provided some comfort that I won't face what Sheila faced. Barry Gleeson is a supporter of Humanists UK. He writes in a personal capacity. But not everyone can afford to go abroad, and there are still legal implications that put my loved ones at risk if they want to join me in my final days. We've spoken about this as a family and my son is happy to take the risk, but it shouldn't have to be this way. Why do I have to leave my own country and subject my family to criminal prosecution in order to die at peace? The assisted dying bill currently being debated in Parliament could change everything. It would give terminally ill people the legal right to die with medical support. It's not about encouraging death – it's about giving people the choice to die with compassion. Polling shows that 75% of the British public support this, so why is it still up for debate? Some people oppose it for religious or moral reasons. I respect that – for them. But their beliefs shouldn't get to decide how I die. More Trending This is about giving people the freedom of choice, to make the decision for themselves. If you've never sat beside someone who's screaming in pain for months, it's easy to talk about hope and palliative care. But for some, like Sheila, even the best hospice care isn't enough. If the law changes, I'll be able to live the rest of my life with peace of mind. Not because I'm in a rush to die, but because I'll know that I don't have to suffer. That I won't have to put my family through what I went through with Sheila. I hope Parliament listens, not just to campaigners, but to the people who've lived through the trauma watching their loved ones die painfully, and the families who can't forget it. Do you have a story you'd like to share? Get in touch by emailing Share your views in the comments below. MORE: The GP thought my 51-year-old husband had depression until he started forgetting things MORE: I married my husband – then we both fell in love with Kasey MORE: I want to enjoy sex but I can't stop worrying about my breasts